Please use this identifier to cite or link to this item:
http://cmuir.cmu.ac.th/jspui/handle/6653943832/74560
Title: | Use of Thiazide Diuretics and Risk of All Types of Skin Cancers: An Updated Systematic Review and Meta-Analysis |
Authors: | Surapon Nochaiwong Mati Chuamanochan Chidchanok Ruengorn Kajohnsak Noppakun Ratanaporn Awiphan Chabaphai Phosuya Napatra Tovanabutra Siri Chiewchanvit Manish M. Sood Brian Hutton Kednapa Thavorn Greg A. Knoll |
Authors: | Surapon Nochaiwong Mati Chuamanochan Chidchanok Ruengorn Kajohnsak Noppakun Ratanaporn Awiphan Chabaphai Phosuya Napatra Tovanabutra Siri Chiewchanvit Manish M. Sood Brian Hutton Kednapa Thavorn Greg A. Knoll |
Keywords: | Biochemistry, Genetics and Molecular Biology;Medicine |
Issue Date: | 1-May-2022 |
Abstract: | Background: The use of thiazide diuretics is associated with skin cancer risk; however, whether this applies to all skin cancer types is unclear. Methods: In this meta-analysis, we searched multiple electronic databases and gray literature up to 10 April 2022, with no language restrictions, to identify relevant randomized controlled trials (RCTs) and non-randomized studies (cohort, casecontrol) that investigated the association between thiazide diuretics and skin cancer. The primary outcomes of interest were malignant melanoma and non-melanoma skin cancer (basal cell carcinoma [BCC], squamous cell carcinoma [SCC]). Secondary outcomes included other skin cancers (lip cancer, Merkel cell carcinoma, malignant adnexal skin tumors, oral cavity cancer, and precursors of skin cancer). We used a random-effects meta-analysis to estimate pooled adjusted odds ratios (ORs) and 95% confidence intervals (CIs). Results: Thirty non-randomized studies (17 case-control, 13 cohort, no RCTs) were included. Thiazide diuretic users had a higher risk of malignant melanoma (17 studies; n = 10,129,196; pooled adjusted OR, 1.10; 95% CI, 1.04–1.15; p < 0.001; strength of evidence, very low; very small harmful effect), BCC (14 studies; n = 19,780,476; pooled adjusted OR, 1.05; 95% CI, 1.02–1.09; p = 0.003; strength of evidence, very low; very small harmful effect), and SCC (16 studies; n = 16,387,862; pooled adjusted OR, 1.35; 95% CI, 1.22–1.48; p < 0.001; strength of evidence, very low; very small harmful effect) than non-users. Thiazide diuretic use was also associated with a higher risk of lip cancer (5 studies; n = 161,491; pooled adjusted OR, 1.92; 95% CI, 1.52–2.42; p < 0.001; strength of evidence, very low; small harmful effect), whereas other secondary outcomes were inconclusive. Conclusions: Thiazide diuretics are associated with the risk of all skin cancer types, including malignant melanoma; thus, they should be used with caution in clinical practice. |
URI: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85130405834&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/74560 |
ISSN: | 20726694 |
Appears in Collections: | CMUL: Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.